Novavax reported $24.58M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Adma Biologics USD 22.52M 1.5M Dec/2025
Agenus USD 82.99M 2.3M Dec/2025
AstraZeneca USD 22.51B 2.78B Mar/2026
BioCryst Pharmaceuticals USD 15.83M 10.26M Dec/2025
Cassava Sciences USD 41.65M 4.44M Dec/2025
Geron USD 11.26M 146K Dec/2025
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
MannKind USD 9.03M 1.76M Dec/2025
Merck USD 3.86B 541M Mar/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Moderna USD 161M 156M Mar/2026
Novartis USD 4.46B 99M Dec/2025
Novavax USD 24.58M 9.35M Dec/2025
Pfizer USD 4.51B 734M Mar/2026
Sanofi EUR 22.71B 219M Mar/2026
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025